Wendy future of retail top

Novo Nordisk to lower U.S. prices of several insulin products

Novo Nordisk to lower U.S. prices of several insulin products

Novo Nordisk to lower U.S. prices of several insulin products

PLAINSBORO, N.J. — Novo Nordisk announced it is lowering the U.S. list prices of several insulin products by up to 75% for people living with type 1 and type 2 diabetes. Products include both pre-filled pens and vials of basal (long-acting), bolus (short-acting) and pre-mix insulins, specifically Levemir, Novolin, NovoLog and NovoLog Mix 70/30. Novo

PP_1170x120_10-25-21